Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | FDPS | P14324 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 7/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20779495 | 0.88 | ALDH1A1 (0.42) | TSHRFDPSCA2MAPK1CA1 | |
| SCHEMBL20779323 | 0.80 | FDPS (0.38) | TSHRFDPSCA2MAPK1CA1 | |
| SCHEMBL11830840 | 0.79 | ALDH1A1 (0.45) | TSHRFDPSCA2MAPK1CA1 | |
| SCHEMBL10242782 | 0.78 | FDPS (0.45) | TSHRFDPSCA2MAPK1CA1 | |
| SCHEMBL20779256 | 0.77 | FDPS (0.36) | TSHRFDPSCA2MAPK1CA1 | |
| SCHEMBL28367268 | 0.75 | FDPS (0.47) | TSHRFDPSCA2MAPK1CA1 | |
| SCHEMBL11496837 | 0.74 | CA2 (0.42) | TSHRFDPSCA2MAPK1CA1 | |
| SCHEMBL20779314 | 0.74 | TSHR (0.38) | TSHRFDPS | |
| SCHEMBL8634496 | 0.74 | TSHR (0.61) | TSHRALDH1A1 | |
| SCHEMBL5137741 | 0.73 | FDPS (0.45) | TSHRFDPSCA2MAPK1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019046271-A1 | HEPATITIS B ANTIVIRAL AGENTS | ENANTA PHARMACEUTICALS, INC. (US) | 2019-03-07 | — | — | WO | disclosed |